Somatodendritic Dopamine Release in Midbrain

[1]  S. Cragg,et al.  DAncing past the DAT at a DA synapse , 2004, Trends in Neurosciences.

[2]  J. Zhang,et al.  Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: in vivo microdialysis study , 2003, Neuroscience Letters.

[3]  F. Bergquist,et al.  Influence of r-type (Cav2.3) and t-type (Cav3.1–3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis , 2003, Neuroscience.

[4]  Nicolas Le Novère,et al.  Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice , 2003, The Journal of Neuroscience.

[5]  F. Bergquist,et al.  Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod , 2003, Brain Research.

[6]  F. Bergquist,et al.  Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo , 2002, Brain Research.

[7]  A. Carlsson,et al.  Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems , 2002, Journal of Neural Transmission.

[8]  M. Rice,et al.  Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area , 2002, Journal of neurochemistry.

[9]  T. Südhof.  Synaptotagmins: Why So Many?* , 2002, The Journal of Biological Chemistry.

[10]  M. Wolf,et al.  In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABAB receptors is altered after repeated amphetamine treatment , 2002, Neuroscience.

[11]  M. Rice,et al.  Modulation of somatodendritic dopamine release by endogenous H(2)O(2): susceptibility in substantia nigra but resistance in VTA. , 2002, Journal of neurophysiology.

[12]  F. Gonon,et al.  Inhibition of Dopamine Release Via Presynaptic D2 Receptors: Time Course and Functional Characteristics In Vivo , 2001, The Journal of Neuroscience.

[13]  M. Rice,et al.  Novel Ca2+ Dependence and Time Course of Somatodendritic Dopamine Release: Substantia Nigra versus Striatum , 2001, The Journal of Neuroscience.

[14]  B. Falkenburger,et al.  Dendrodendritic Inhibition Through Reversal of Dopamine Transport , 2001, Science.

[15]  P. Illés,et al.  Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo , 2001, Neuropharmacology.

[16]  C. Nicholson,et al.  Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. , 2001, Journal of neurophysiology.

[17]  V. Leviel.  The reverse transport of DA, what physiological significance? , 2001, Neurochemistry International.

[18]  J. Stamford,et al.  Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by ‘regular’ and ‘burst’ firing , 2000, Brain Research.

[19]  C. Fiorillo,et al.  Cholinergic Inhibition of Ventral Midbrain Dopamine Neurons , 2000, The Journal of Neuroscience.

[20]  M. Reuben,et al.  Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically. , 2000, European journal of pharmacology.

[21]  T. Momiyama,et al.  Presynaptic dopamine D2‐like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones , 2000, The Journal of physiology.

[22]  I. Parnas,et al.  Autoreceptors, membrane potential and the regulation of transmitter release , 2000, Trends in Neurosciences.

[23]  G. Gerhardt,et al.  Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.

[24]  W. Catterall.  Interactions of Presynaptic Ca2+ Channels and Snare Proteins in Neurotransmitter Release , 1999, Annals of the New York Academy of Sciences.

[25]  T. Miyazaki,et al.  Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata , 1998, The Journal of physiology.

[26]  G. Gerhardt,et al.  Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. , 1998, The Journal of pharmacology and experimental therapeutics.

[27]  R. Wightman,et al.  Quantitative Evaluation of 5-Hydroxytryptamine (Serotonin) Neuronal Release and Uptake: An Investigation of Extrasynaptic Transmission , 1998, The Journal of Neuroscience.

[28]  A. Marty,et al.  Extrasynaptic Vesicular Transmitter Release from the Somata of Substantia Nigra Neurons in Rat Midbrain Slices , 1998, The Journal of Neuroscience.

[29]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[30]  G. Radnikow,et al.  Dopamine D1 Receptors Facilitate GABAASynaptic Currents in the Rat Substantia Nigra Pars Reticulata , 1998, The Journal of Neuroscience.

[31]  J. Changeux,et al.  Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.

[32]  S. Greenfield,et al.  Comparison of Serotonin and Dopamine Release in Substantia Nigra and Ventral Tegmental Area: Region and Species Differences , 1997, Journal of neurochemistry.

[33]  V. Pickel,et al.  The Dopamine Transporter: Comparative Ultrastructure of Dopaminergic Axons in Limbic and Motor Compartments of the Nucleus Accumbens , 1997, The Journal of Neuroscience.

[34]  H. Nissbrandt,et al.  Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices , 1997, Synapse.

[35]  S. Cragg,et al.  Differential Autoreceptor Control of Somatodendritic and Axon Terminal Dopamine Release in Substantia Nigra, Ventral Tegmental Area, and Striatum , 1997, The Journal of Neuroscience.

[36]  S. Cragg,et al.  Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. , 1997, Journal of neurophysiology.

[37]  S. Cragg,et al.  Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. , 1997, Journal of neurophysiology.

[38]  M. Geffard,et al.  Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra , 1997, Neuroscience.

[39]  Z. Kruk,et al.  Real‐time measurement of stimulated 5‐hydroxytryptamine release in rat substantia nigra pars reticulata brain slices , 1997, Synapse.

[40]  M. Delong,et al.  Functional and pathophysiological models of the basal ganglia , 1996, Current Opinion in Neurobiology.

[41]  Josep Rizo,et al.  Synaptotagmins: C2-Domain Proteins That Regulate Membrane Traffic , 1996, Neuron.

[42]  E. Abercrombie,et al.  Amphetamine‐induced release of dendritic dopamine in substantia nigra pars reticulata: D1‐mediated behavioral and electrophysiological effects , 1996, Synapse.

[43]  V. Pickel,et al.  Ultrastructural Localization of the Vesicular Monoamine Transporter-2 in Midbrain Dopaminergic Neurons: Potential Sites for Somatodendritic Storage and Release of Dopamine , 1996, The Journal of Neuroscience.

[44]  Z. Kruk,et al.  Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens , 1996, Neuroscience.

[45]  M. Kuhar,et al.  The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  G. Uhl,et al.  Dopamine transporter immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[47]  E. Abercrombie,et al.  Biochemistry of Somatodendritic Dopamine Release in Substantia Nigra: An In Vivo Comparison with Striatal Dopamine Release , 1995, Journal of neurochemistry.

[48]  D. Sulzer,et al.  Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[49]  A. D. Smith,et al.  Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy , 1995, Neuroscience.

[50]  S. Hersch,et al.  The dopamine transporter: immunochemical characterization and localization in brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  J. Luebke,et al.  Exocytotic Ca2+ channels in mammalian central neurons , 1995, Trends in Neurosciences.

[52]  Y. Hurd,et al.  The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons , 1994, Neuroscience.

[53]  M. Sanghera,et al.  Low dopamine transporter mRNA levels in midbrain regions containing calbindin. , 1994, Neuroreport.

[54]  C. Nicholson,et al.  Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro , 1994, Experimental Brain Research.

[55]  S. Hernández,et al.  Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat , 1994, Brain Research.

[56]  A. Nieoullon,et al.  Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain , 1994, Neuropharmacology.

[57]  Y. Agid,et al.  Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. , 1994, Brain research. Molecular brain research.

[58]  M. Desban,et al.  NMDA regulation of dopamine release from proximal and distal dendrites in the cat substantia nigra , 1994, Brain Research.

[59]  S. Sesack,et al.  Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  Colin Davidson,et al.  Simultaneous “real-time” electrochemical and electrophysiological recording in brain slices with a single carbon-fibre microelectrode , 1993, Journal of Neuroscience Methods.

[61]  M. Caron,et al.  Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  G. Doucet,et al.  Ultrastructure and synaptic targets of the raphe-nigral projection in the rat , 1993, Neuroscience.

[63]  Luigi F. Agnati,et al.  Volume transmission in the brain. Novel mechanisms for neural transmission Edited by K. Fuxe and L.F. Agnati, Advances in neuroscience vol. 1, Raven Press, New York, 1991, 602 pp., US$ 130,- , 1992, Neuroscience Letters.

[64]  H. Nissbrandt,et al.  Effects of (d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum , 1992, Neuropharmacology.

[65]  Z. Kruk,et al.  Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors , 1992, British journal of pharmacology.

[66]  B. Westerink,et al.  The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[67]  L. Chiodo.  Dopamine autoreceptor signal transduction in the DA cell body: A “current view” , 1992, Neurochemistry International.

[68]  B. Westerink,et al.  Simultaneous recording of the release of nigral and striatal dopamine in the awake rat , 1992, Neurochemistry International.

[69]  Z. Kruk,et al.  “Real time” measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens : role of autoinhibition , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[70]  J. A. Jankowski,et al.  Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[71]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[72]  B. Westerink,et al.  Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats , 1991, Journal of neurochemistry.

[73]  H. Nissbrandt,et al.  Reserpine-insensitive dopamine release in the substantia nigra? , 1991, Brain Research.

[74]  G. Engberg,et al.  The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[75]  G. Damsma,et al.  Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[76]  W. Gibb,et al.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[77]  P. Kalivas,et al.  A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis , 1991, Journal of neurochemistry.

[78]  G. Paxinos,et al.  Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography , 1991, The Journal of comparative neurology.

[79]  C. Nicholson,et al.  Diffusion characteristics and extracellular volume fraction during normoxia and hypoxia in slices of rat neostriatum. , 1991, Journal of neurophysiology.

[80]  P. Mcgeer,et al.  Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K , 1990, Brain Research.

[81]  V M Pickel,et al.  Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabeling density and neuronal associations , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[82]  A. Parent,et al.  Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey , 1990, The Journal of comparative neurology.

[83]  N. Mercuri,et al.  Actions of cocaine on rat dopaminergic neurones in vitro , 1990, British journal of pharmacology.

[84]  H. Robertson,et al.  Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[85]  B. Bunney,et al.  Ionic Composition of Microdialysis Perfusing Solution Alters the Pharmacological Responsiveness and Basal Outflow of Striatal Dopamine , 1989, Journal of neurochemistry.

[86]  R. Araneda,et al.  Modulation of Dendritic Release of Dopamine by N‐Methyl‐D‐Aspartate Receptors in Rat Substantia Nigra , 1989, Journal of neurochemistry.

[87]  R. Roth,et al.  Telencephalic Projections of the A8 Dopamine Cell Group , 1988, Annals of the New York Academy of Sciences.

[88]  N. Mercuri,et al.  On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. , 1988, The Journal of physiology.

[89]  J. Bolam,et al.  Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra , 1988, Nature.

[90]  D. German,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost? , 1988, Neuroscience.

[91]  C. Gerfen,et al.  The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[92]  C. Gerfen,et al.  The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[93]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[94]  M. Martres,et al.  A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride , 1987, Neuroscience.

[95]  E. Sundström,et al.  Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice. , 1986, European journal of pharmacology.

[96]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[97]  C. Sotelo,et al.  Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration , 1981, Neuroscience.

[98]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[99]  J. Glowinski,et al.  Dendritic release of dopamine in the substantia nigra , 1981, Nature.

[100]  A. Cuello,et al.  Dopamine release from the rat substantia nigra in vitro. Effect of raphe lesions and veratridine stimulation , 1979, Neuroscience.

[101]  A. Cuello,et al.  The smooth endoplasmic reticulum as a possible storage site for dendritic dopamine in substantia nigra neurones , 1979, Experientia.

[102]  J. Fallon,et al.  Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum , 1978, The Journal of comparative neurology.

[103]  J. Fallon,et al.  Substantia nigra dopamine neurons: separate populations project to neostriatum and allocortex , 1978, Neuroscience Letters.

[104]  P. Groves,et al.  Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra , 1977, Experimental Brain Research.

[105]  P. Groves,et al.  The substantia nigra of the rat: A golgi study , 1977, The Journal of comparative neurology.

[106]  J. Glowinski,et al.  Release of dopamine in vivo from cat substantia nigra , 1977, Nature.

[107]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[108]  S J Young,et al.  Self-inhibition by dopaminergic neurons , 1975, Science.

[109]  O. Lindvall,et al.  Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals , 1975, Brain Research.

[110]  F. Dodge,et al.  On the relationship between calcium concentration and the amplitude of the end-plate potential. , 1967, The Journal of physiology.

[111]  W. Douglas,et al.  The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus—secretion coupling , 1963, The Journal of physiology.

[112]  P. Groves,et al.  Dendro-dendritic synapses in substantia nigra: Descriptions based on analysis of serial sections , 2004, Experimental Brain Research.

[113]  R. Gainetdinov,et al.  Plasma membrane monoamine transporters: structure, regulation and function , 2003, Nature Reviews Neuroscience.

[114]  M. Rice,et al.  Distinct regional differences in dopamine-mediated volume transmission. , 2000, Progress in brain research.

[115]  V. M. Pickel.  Extrasynaptic distribution of monoamine transporters and receptors. , 2000, Progress in brain research.

[116]  A. Crocker.  The Regulation of Motor Control: An Evaluation of the Role of Dopamine Receptors in the Substantia Nigra , 1997, Reviews in the neurosciences.

[117]  Micaela Morelli,et al.  The Basal Ganglia III , 1991, Advances in Behavioral Biology.

[118]  D. H. Mellor,et al.  Real time , 1981 .